GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Valuation Rank

Abbott India (BOM:500488) Valuation Rank


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Abbott India Valuation Rank Related Terms

Thank you for viewing the detailed overview of Abbott India's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott India (BOM:500488) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Valuation Rank
Comparable Companies
NSE:GLAND BOM:500660 NSE:PFIZER BOM:500674 NSE:MARKSANS BOM:507747 BOM:500087 BOM:524774 BOM:524280 BOM:532815 LLY JNJ MRK ABBV XSWX:ROG XSWX:NOVN LSE:AZN PFE AMGN XPAR:SAN
Traded in Other Exchanges
ABBOTINDIA:India
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Website
https://www.abbott.co.in
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.